HMGCR and familial hypercholesterolemia: Reduction of MVP by HMGCR statin inhibitors, the most widely used drugs worldwide for the treatment of hypercholesterolemia, has been shown to exert antitumor effects through a variety of distinct mechanisms, such as increased oxidative stress and apoptosis [52], induction of cell cycle arrest, and inhibition of cell proliferation and invasion [34].